Call Us Today
Schedule Your Consultation
or email us

Friday, September 11, 2015

Gynecomastia and Risperdal

Gynecomastia and Risperdal Update

San Jose, California - Risperdal is an antipsychotic drug manufactured by Janssen Pharmaceuticals, which is a subsidiary of Johnson and Johnson. At one time, the drug was the most widely sold antipsychotic in the United States. However, it became apparent that it had severe side effects, mainly gynecomastia, which is the development of male breasts. It is believed that Risperdal raises prolactin levels while blocking dopamine.  Male breasts added an extreme amount of anguish to boys and men already suffering with mental illness.
Johnson and Johnson’s battles in court about the side effects of Risperdal turned out to be one of the longest in history for the drug industry. In September of 2012, the first case went to trial but was settled outside of court for an undisclosed amount on the first day. There were five more cases settled in 2012, and to date there are pending over 1300 unresolved cases in the Philadelphia Court of Common Pleas.
If you were to Google “Risperdal lawsuits,” you would find multiple attorneys offering their services for representation. Law firms state that there is a settlement in progress with large payouts possible. However, this is not categorized as a class action suit. A class action suit means there would be one lump sum awarded and then it would be divided equally for all plaintiffs. Instead, it is being heard by one judge in one courtroom as a Multidistrict Litigation, which speeds up the process of handling complex cases, such as product liability. Plaintiffs are then able to negotiate their own settlement with their Risperdal attorney, based on their degree of injury.

So far, Johnson and Johnson has paid out to the Department of Justice, 2.2 billion dollars for Janssen’s guilty plea of misbranding of Risperdal.
Bellwether trials help give an indication of how juries will react to testimony, thus influencing future settlements and negotiations. So far there have been three bellwether trials for Risperdal. The first trial was in February 2015, for a 20-year- old man who had been taking Risperdal for autism since he was 8 years old. Johnson and Johnson was ordered to pay 2.5 million dollars. The second trial went in favor of the defense as there was not enough evidence to prove male breasts were caused by the drug. In the third case, the settlement went to the plaintiff for an unknown amount.
Miguel Delgado, M.D. advises patients that suffer from gynecomastia that may have been caused by Risperdal, to seek the expert opinion of a Board Certified Plastic Surgeon, who specializes in gynecomastia. Also, perhaps seek the advice of a Risperdal attorney. However, each state has its own statute of limitations, and time may be of the essence.
Miguel Delgado, M.D. has been a gynecomastia specialist since 1989 and invites you to call (415) 898-4161 or email ( a consultation if you have any concerns about male breasts.

No comments:

Post a Comment